Diabetes Induces Permanent Deleterious Effects in the Olfactory Bulb Associated with Increased Tyrosine Hydroxylase...

Area of Science:

• Neuroscience
• Endocrinology
• Pathology

Background:

• Type 2 diabetes (T2D) is associated with brain complications, including neurodegenerative diseases and dementia.
• Olfactory dysfunction (OD) is an early sign of neurodegeneration and is observed in diabetic patients.
• Previous studies linked OD in a T2D rodent model to inflammation (IL-1β and miR-146a) in the olfactory bulb (OB).

Purpose of the Study:

• To investigate the long-term effects of T2D on olfactory function and the underlying mechanisms in the olfactory bulb.
• To explore the role of dopaminergic signaling and ERK1/2 pathway in T2D-associated olfactory dysfunction.

Main Methods:

• Assessment of olfactory function in a long-term T2D rodent model.
• Analysis of olfactory bulb tissue for inflammatory markers (IL-1β), microRNA (miR-146a), dopaminergic markers (tyrosine hydroxylase), and neuronal activation markers (ERK1/2 phosphorylation).

Main Results:

• Olfactory dysfunction persisted in T2D rats even after IL-1β downregulation.
• Increased expression of tyrosine hydroxylase and ERK1/2 phosphorylation was observed in the OB of diabetic rats.
• Reduced neuronal activation was noted in the OB of diabetic rats, suggesting altered dopaminergic tone.

Conclusions:

• Long-term T2D is associated with persistent olfactory dysfunction.
• The dopaminergic system, including tyrosine hydroxylase and ERK1/2 signaling, appears to be involved in T2D-derived olfactory impairment.
• Further research is needed to fully understand the role of dopaminergic neurons and ERK1/2 signaling in T2D-related olfactory dysfunction, particularly in relation to neurodegenerative diseases like Parkinson's.